ArticleDiagnostics (Basel, Switzerland)2023

Chemo-Free Treatment Using Anti-PD-1 Antibodies with Lenvatinib in Unresectable Gallbladder Cancer: PD-L1 May Be a Potential Biomarker for a Better Outcome.

Tiantian Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.